Niagen Bioscience Inc (NAGE) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 105.12M | 96.81M | 93.62M | 86.68M | 76.22M | 64.1M | 52.13M | 49.3M | 48.98M | 49.53M | 47.18M | 46.38M |
| Cash & Short-Term Investments | 66.55M | 64.79M | 64.14M | 60.32M | 55.46M | 44.51M | 32.25M | 27.73M | 27.41M | 27.17M | 26.62M | 26.25M |
| Cash Only | 66.55M | 64.79M | 64.14M | 60.32M | 55.46M | 44.51M | 32.25M | 27.73M | 27.41M | 27.17M | 26.62M | 26.25M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 13.07M | 9.74M | 8.51M | 9.66M | 7.05M | 7.77M | 7.1M | 7.82M | 6.6M | 5.23M | 5.6M | 6.12M |
| Days Sales Outstanding | 32.61 | 24.8 | 24.58 | 24.43 | 21.88 | 23.48 | 26.82 | 28.86 | 24.31 | 23.51 | 27.65 | 34.34 |
| Inventory | 24.02M | 20.42M | 18.79M | 14.41M | 11.19M | 9.19M | 10.54M | 11.51M | 12.49M | 14.53M | 12.62M | 11.97M |
| Days Inventory Outstanding | 173.93 | 148.65 | 126.64 | 106.91 | 82.24 | 83.08 | 108.62 | 120.75 | 141.36 | 151.21 | 150.34 | 136.39 |
| Other Current Assets | 1.49M | 1.85M | 752K | 2.29M | 2.52M | 2.63M | 2.25M | 2.24M | 2.46M | 2.6M | 2.33M | 2.04M |
| Total Non-Current Assets | 9.21M | 9.6M | 4.52M | 4.85M | 5.12M | 4.18M | 4.39M | 4.73M | 5.1M | 5.43M | 6.3M | 6.79M |
| Property, Plant & Equipment | 3.32M | 3.52M | 3.86M | 4.16M | 4.34M | 3.45M | 3.62M | 3.9M | 4.23M | 4.54M | 5.3M | 5.68M |
| Fixed Asset Turnover | 9.21x | 9.18x | 8.48x | 7.33x | 7.83x | 8.24x | 6.80x | 5.59x | 5.06x | 4.31x | 3.55x | 3.47x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 5.49M | 5.66M | 246K | 284K | 322K | 359K | 397K | 435K | 472K | 510K | 552K | 591K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 406K | 425K | 417K | 405K | 458K | 368K | 374K | 394K | 405K | 383K | 454K | 518K |
| Total Assets | 114.33M | 106.41M | 98.14M | 91.53M | 81.34M | 68.28M | 56.52M | 54.03M | 54.08M | 54.96M | 53.48M | 53.17M |
| Asset Turnover | 0.29x | 0.33x | 0.36x | 0.36x | 0.41x | 0.47x | 0.46x | 0.42x | 0.41x | 0.39x | 0.37x | 0.38x |
| Asset Growth % | 40.56% | 55.84% | 73.63% | 69.38% | 50.4% | 24.22% | 5.68% | 1.62% | 0.58% | 1.68% | 17.12% | 14.07% |
| Total Current Liabilities | 22.82M | 19.92M | 22.71M | 22.33M | 20.84M | 17.95M | 17.7M | 17.87M | 19.45M | 20.62M | 19.44M | 19.06M |
| Accounts Payable | 13.28M | 10.8M | 12.74M | 13.68M | 10.63M | 8.53M | 6.9M | 8.11M | 7.9M | 10.23M | 9.2M | 10.03M |
| Days Payables Outstanding | 94.22 | 89.23 | 100.8 | 101.57 | 77.32 | 64.95 | 73.92 | 80.5 | 94.86 | 108.22 | 117.53 | 108.41 |
| Short-Term Debt | 1.03M | 1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 303K | 207K | 611K | 184K | 156K | 227K | 195K | 189K | 166K |
| Other Current Liabilities | 8.52M | 8.12M | 292K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio | 4.61x | 4.86x | 4.12x | 3.88x | 3.66x | 3.57x | 2.95x | 2.76x | 2.52x | 2.40x | 2.43x | 2.43x |
| Quick Ratio | 3.55x | 3.83x | 3.29x | 3.24x | 3.12x | 3.06x | 2.35x | 2.12x | 1.88x | 1.70x | 1.78x | 1.81x |
| Cash Conversion Cycle | 112.32 | 84.23 | 50.43 | 29.77 | 26.8 | 41.61 | 61.53 | 69.11 | 70.82 | 66.51 | 60.46 | 62.32 |
| Total Non-Current Liabilities | 9.17M | 9.95M | 4.75M | 5M | 5.16M | 4.24M | 4.45M | 5.45M | 5.68M | 5.89M | 6.73M | 6.96M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 1.54M | 1.81M | 2.08M | 2.33M | 2.58M | 1.66M | 1.88M | 2.14M | 2.37M | 2.58M | 2.92M | 3.15M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 5.06M | 5.46M | 2.67M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 32M | 29.87M | 27.46M | 27.33M | 25.99M | 22.18M | 22.15M | 23.32M | 25.13M | 26.51M | 26.18M | 26.02M |
| Total Debt | 2.58M | 2.82M | 3.06M | 3.29M | 3.52M | 2.65M | 2.9M | 3.12M | 3.23M | 3.28M | 3.79M | 3.94M |
| Net Debt | -63.97M | -61.97M | -61.08M | -57.03M | -51.94M | -41.86M | -29.35M | -24.61M | -24.19M | -23.9M | -22.83M | -22.32M |
| Debt / Equity | 0.03x | 0.04x | 0.04x | 0.05x | 0.06x | 0.06x | 0.08x | 0.10x | 0.11x | 0.12x | 0.14x | 0.15x |
| Debt / EBITDA | 1.38x | 0.95x | 0.69x | 0.93x | 0.69x | 0.35x | 1.47x | 27.40x | - | 15.99x | - | - |
| Net Debt / EBITDA | -34.27x | -20.89x | -13.79x | -16.11x | -10.11x | -5.60x | -14.91x | -215.87x | - | -116.57x | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 82.33M | 76.53M | 70.68M | 64.19M | 55.34M | 46.09M | 34.37M | 30.72M | 28.95M | 28.46M | 27.31M | 27.15M |
| Equity Growth % | 48.76% | 66.04% | 105.64% | 108.98% | 91.17% | 61.98% | 25.86% | 13.14% | 3.33% | -0.75% | 29.9% | 30.67% |
| Book Value per Share | 0.97 | 0.91 | 0.82 | 0.74 | 0.66 | 0.56 | 0.44 | 0.41 | 0.38 | 0.38 | 0.36 | 0.36 |
| Total Shareholders' Equity | 82.33M | 76.53M | 70.68M | 64.19M | 55.34M | 46.09M | 34.37M | 30.72M | 28.95M | 28.46M | 27.31M | 27.15M |
| Common Stock | 79K | 79K | 79K | 79K | 78K | 77K | 76K | 75K | 75K | 75K | 75K | 75K |
| Retained Earnings | -158.21M | -164.53M | -168.66M | -173.24M | -176.85M | -181.91M | -189.09M | -190.97M | -190.95M | -190.46M | -190.57M | -189.62M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -3K | -9K | -9K | -4K | -5K | -4K | -7K | -2K | -1K | -4K | -1K | -1K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |